SPY313.78-3.27 -1.03%
DIA259.04-3.96 -1.51%
IXIC10,343.89-89.76 -0.86%

Citius Pharma Reports Will Deliver Virtual Presentation At Life Sciences Investor Forum Thurs., Jun. 25 At 11 a.m. EDT

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ:CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that

Benzinga · -

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ:CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that Chief Executive Officer Myron Holubiak will deliver a virtual presentation at the Life Sciences Investor Forum on Thursday, June 25, 2020 at 11:00 AM ET. 

Event: Life Sciences Investor Forum

Presentation Date: Thursday, June 25, 2020

Presentation Time: 11:00 AM ET

Mr. Myron Holubiak will present an update on the Company, including its Phase 3 pivotal trial with Mino-Lok® that is currently more than half enrolled and its option to license a novel stem cell therapy for acute respiratory distress syndrome (ARDS) in COVID-19 patients. This presentation will be a live, interactive online event where investors can ask the Company questions in real-time. An archived webcast will also be made available after the event.

While attendance at this virtual event is free, it is recommended that investors pre-register at www.lifesciencesinvestorforum.com.